eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 02/02/2012
PIL Eloxatin 5 mg/ml concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/02/2012 and displayed until Current
Reasons for adding or updating:
  • Unknown
Updated on 14/06/2011 and displayed until 02/02/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to dosage and administration
  • PIL Product / presentation discontinued
Updated on 12/04/2010 and displayed until 14/06/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 09/09/2009 and displayed until 12/04/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 15/08/2006 and displayed until 09/09/2009
Reasons for adding or updating:
  • Introduction of new strength
Updated on 13/02/2006 and displayed until 15/08/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   oxaliplatin